Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Nutex Health (NUTX) Return on Invested Capital (2021 - 2025)

Nutex Health's Return on Invested Capital history spans 6 years, with the latest figure at 39.28% for Q4 2025.

  • For Q4 2025, Return on Invested Capital rose 3847.0% year-over-year to 39.28%; the TTM value through Dec 2025 reached 39.28%, up 3847.0%, while the annual FY2025 figure was 2.1%, 128.0% up from the prior year.
  • Return on Invested Capital for Q4 2025 was 39.28% at Nutex Health, up from 1.63% in the prior quarter.
  • Across five years, Return on Invested Capital topped out at 39.28% in Q4 2025 and bottomed at 3.09% in Q2 2023.
  • The 5-year median for Return on Invested Capital is 0.12% (2021), against an average of 1.71%.
  • The largest annual shift saw Return on Invested Capital plummeted -319bps in 2023 before it skyrocketed 3847bps in 2025.
  • A 5-year view of Return on Invested Capital shows it stood at 0.15% in 2021, then crashed by -1879bps to 2.59% in 2022, then surged by 89bps to 0.27% in 2023, then skyrocketed by 397bps to 0.81% in 2024, then soared by 4724bps to 39.28% in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Return on Invested Capital are 39.28% (Q4 2025), 1.63% (Q3 2025), and 0.61% (Q2 2025).